ETCapital
Venture capitalCambridge · Pre-Seed–Series A · 3 people tracked
Find your way into ETCapital
1,142 people in our graph share verified history with the ETCapital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
ET Capital invests in high-growth companies applying technology innovation, concentrating on science-based businesses in the Cambridge, Oxford and London cluster. The firm raises and manages a series of funds, having backed ambitious entrepreneurs building outstanding businesses, three of which went public and eight of which achieved profitable exits. Through vehicles such as Cambridge Research & Innovation, UK China Enterprise (targeting science-based businesses able to scale in China), Carbon Order (direct-air carbon capture), and the Carbon13 SEIS funds (climate-focused venture builder businesses), it supports early-stage technology and climate ventures. Its early funds were backed by HSBC and the European Investment Fund.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 7 of 16 portfolio companiesDeep Tech ×4AI & Machine Learning ×2Biotech ×2Cleantech ×2Energy ×2Fintech ×2Healthtech ×2New Materials ×2
HQs:Canada×1United Kingdom×1
Investments · 16 tracked
founders shown can be your intro path
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology.
BiotechHealthtechMedical Devices
Ameet Mallik(Chief Executive Officer)inJose Carmona(Chief Financial Officer)Mohamed Zaki(Chief Medical Officer)inKristen Harrington-Smith(Chief Commercial Officer)inDavid Ege(Chief Technical Officer)inPeter Graham(Chief Legal Officer)in
Co-investorsHEALTHCARE ROYALTY PARTNERSScientia Ventures
Bango operates a subscription bundling marketplace platform that connects content providers and telecommunications companies, enabling consumers to purchase bundled subscriptions through telecom carriers and alternative payment methods like direct carrier billing.
B2B MarketplacesEnterprise SoftwareFintechSaaS
CDT is a research and innovation centre focused on developing advanced materials, particularly polymer OLED and next-generation display technologies, with a heritage rooted in Cambridge University spin-out research since 1989.
AI & Machine LearningDeep TechEnergyNew MaterialsCambridge, GB
Richard Friend(Professor)inAndrew Holmes(Professor)
Co-investorsKelso
Carbon Engineering is a Direct Air Capture (DAC) technology company, founded in 2009, that develops systems to capture large volumes of CO2 directly from the atmosphere.
CleantechClimate TechDeep TechSquamish, CA
Co-investorsDesigner FundKhosla VenturesLOWERCARBONLowercarbon CapitalWUTIF CapitalAirbus+3 more
.jpeg){kind=logo}
Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology.
BiotechDeep TechDigital HealthHealthtech
Dr Nat Hastings(Chief Executive Officer)inDr Shawn Manning(Finance & Operations)
Infyos provides a supplier mapping and compliance platform for developers, asset managers, and battery manufacturers to manage regulatory requirements including EU Battery Regulation, UFLPA, and CSRD, while enabling financing and lender due diligence.
CleantechEnergyFintechSaaS
Co-investorsCarbon13Conduit ConnectSatgana
MatNex (Materials Nexus) is a materials design company that uses first-principles computation, machine learning, and materials engineering to design new materials to customer-defined performance and cost specifications, then owns and licenses the resulting material IP.
AI & Machine LearningDeep TechNew Materials
Dr Jonathan Bean(CEO & Co-Founder)Dr Robert Forrest(CTO & Co-Founder)
Co-investorsCarbon13MD One VenturesSamos InvestmentsAda Ventures
.jpeg){kind=logo}
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EquitalkNiumPhicoPlastic LogicPuriFire LabsReo TxSilicon FuelSolcomSpirogen
Exits · 2
1 IPOs · 1 acquisitions · showing 1ADC Therapeutics SANYSE: ADCT
Portfolio news
latest coverage across their companiesADC Therapeutics SA · stocktitan.net · Aug 14, 2026
Bango · investegate.co.uk · Apr 27, 2026
Frequently asked questions
- How many investments has ETCapital made?
- ETCapital has 16 tracked investments, 2 of which have exited.
- What stage does ETCapital invest at?
- ETCapital invests at the Pre-Seed, Seed, Series A stages.
- What is ETCapital's typical check size?
- ETCapital typically writes checks of $100K – $952.5K.
- What sectors does ETCapital focus on?
- ETCapital focuses on Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Deep Tech, Enterprise Software, Hardware, Medical Devices, New Materials, SaaS.
- Where is ETCapital located?
- ETCapital is headquartered in Cambridge, GB.
- Does ETCapital lead rounds?
- ETCapital typically participates in rounds rather than leading them.
- Who does ETCapital co-invest with?
- ETCapital most often shares deals with Carbon13, Designer Fund, Khosla Ventures, among 12 tracked co-investors.
Images
Similar investors
Innovobot is an investment and innovation platform focused on deep tech, combining a venture fund (IRV), an innovation studio (Innovobot Labs), and engineering services to foster technologies that address social, industrial and environmental challenges.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
VantagePoint Capital Partners is a global venture investor backing companies from startup through scale-up, with a particular focus on energy innovation and efficiency.
Hercules Capital is a business development company specializing in venture lending, providing flexible debt and equity capital to venture-backed companies in the life sciences and technology sectors.